~~<i id='0EF4C0D970'><strike id='0EF4C0D970'><tt id='0EF4C0D970'><pre id='0EF4C0D970'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：entertainment 2025-08-23 04:59:15 - browse：34537

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Today's health inequities arise from racist U.S. history, say experts

hotspot

focus

knowledge

Wikipedia

explore

entertainment

AdobeThreemonthsago,myauntMargarethadastroke.Daysbefore,shewasrepaintingherbathroomanddrivingherself

WSS

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Weight loss drugs should be covered by insurers, AMA says

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Medical school prerequisites are outdated

Wegovy, Zepbound and weight loss drugs that preserve muscle

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

knowledge

fashion

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Cancer diagnosis changes perspective doctor, former hospital CEO

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Anesthesiologist group: stop taking Ozempic before surgery

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Wildfire smoke exposes gaps in outdoor worker protections

Wegovy, Zepbound and weight loss drugs that preserve muscle

Dobbs anniversary: the lost opportunity of abortion as health care

World's first CRISPR

focus

Childhood cancer progress stalls for Black, Hispanic kids: Report

Medicare’s new pay boost for primary care is angering specialists

A daunting task: navigating dual Medicare, Medicaid eligibility

Healthy food access boosts outcomes in two studies

Hospitals look to new technology to keep health care workers safe

Weight loss drug costs may need more research, senator suggests

knowledge

Wikipedia

explore

entertainment